Russell Exchange Traded Funds Trust ONEF 深 滬
等待開盤 03-26 09:30:00 美东时间
0.00
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 總市值 0
- 52周最高 0.00
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.00
- 委 比 0.00%
- 總股本 --
- 歷史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 0.00
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Chaince Digital appoints Apex Group; Apex oversees $3.5 trillion in assets
Chaince Digital appoints Apex Group; Apex oversees $3.5 trillion in assets Chaince Digital appointed Apex Group to deliver digital asset servicing, tokenization technology, and operational infrastructure for its institutional-grade digital asset platform and tokenized investment strategy. Apex Group
03-25 21:03
DoubleVerify partners with Spectrum Reach; Spectrum Reach joins DV's Certified Transparent Streaming program
DoubleVerify partners with Spectrum Reach; Spectrum Reach joins DV's Certified Transparent Streaming program DoubleVerify entered a partnership with Spectrum Reach to enhance transparency and performance across streaming TV campaigns. Spectrum Reach became the first partner to join DV's Certified Tr
03-25 21:03
Micron Technology announces cash tender offers; senior notes targeted total $5.4 billion
Micron Technology announces cash tender offers; senior notes targeted total $5.4 billion Micron commenced cash Tender Offers to purchase any and all of certain outstanding senior notes, spanning maturities from 2031 to 2035. Notes targeted include $1.0 billion of 5.300% Senior Notes due 2031 and $1.
03-25 20:18
BIO-key hosts year-end investor call; results issue before market open
BIO-key hosts year-end investor call; results issue before market open BIO-key will host its year-end investor call on Tuesday, March 31 at 10 a.m. ET, with results issued prior the market opening. The live webcast and replay will be available at https://event.choruscall.com/mediaframe/webcast.html?
03-25 19:58
EDAP TMS FY2025 net loss widened to €25.9 million; HIFU revenue rose 39% to €33.1 million
EDAP TMS FY2025 net loss widened to €25.9 million; HIFU revenue rose 39% to €33.1 million FY2025 net loss widened 36% to €25.9 million. FY2025 loss per share widened to €0.69 from €0.51. FY2025 HIFU revenue climbed 39% to €33.1 million on increased Focal One system sales and higher U.S. procedure vo
03-25 19:31
Rekor Systems appoints Marc Segal as Rekor Command technical account management director; Jeanus Ko continues as product director
Rekor Systems appoints Marc Segal as Rekor Command technical account management director; Jeanus Ko continues as product director Rekor Systems appointed Marc Segal as Technical Account Management Director of Rekor Command, the company’s real-time traffic operations and incident management platform.
03-25 19:30
Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer
Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer Vera Therapeutics appointed Jane Wright-Mitchell as Chief Legal Officer, effective immediately. Wright-Mitchell previously served as a fractional general counsel supporting public and private life sciences companies. Her prior roles
03-25 19:30
Maze Therapeutics FY2025 operating loss widens 30.01% to $143 million; net loss rises 151.05% to $131 million
Maze Therapeutics FY2025 operating loss widens 30.01% to $143 million; net loss rises 151.05% to $131 million FY2025 net loss widened to $131 million, while FY2025 loss per share widened to $3.05. FY2025 operating loss deepened to $143 million. FY2025 R&D expenses rose 30% to $108 million on higher
03-25 19:04
Winnebago FY2026 Q2 operating income climbs 50.7% to $11.8 million; net revenues rise 6% to $657.4 million
Winnebago FY2026 Q2 operating income climbs 50.7% to $11.8 million; net revenues rise 6% to $657.4 million FY2026 Q2 profit rose to $0.17 per diluted share, while adjusted earnings per diluted share climbed 42.1% to $0.27. FY2026 Q2 operating income jumped 50.7% to $11.8 million. FY2026 Q2 net incom
03-25 19:04
Energous FY2025 net loss narrows 48% to $(9.6) million; revenue jumps 633% to $5.6 million
Energous FY2025 net loss narrows 48% to $(9.6) million; revenue jumps 633% to $5.6 million FY2025 net loss narrowed 48% to $(10) million. FY2025 loss per share narrowed to $(6.46). FY2025 revenue rose 633% to $6 million. FY2025 gross margin increased to 36% from about 2%. CEO and CFO Mallorie Burak
03-25 19:04
